Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Two Edoxaban 60 mg Tablet Formulations in Healthy Thai Subjects (Fasting)
TCTR20240325004Phase 1Completed
- Sponsor
- Sandoz
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of edoxaban (2 arms), sponsored by Sandoz. Started Jun 2024; status: completed.
02
Drugs
edoxaban
Beyond the preview
Go deeper on TCTR20240325004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240325004.